The same applies to a possible association with clinically aggressive behavior of tumours [7], which may be explained by correlation with estrogen receptor negativity [8,9], high Ki-67 level [9] and poor differentiation of tumours (high grade) [10,11]. This evidence concerns the gene ESR1 and neoplasm.